Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 15:00 source : Www.biospace.com save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.4%
H: 3.01%
C: 2.94%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | $2.16 6.93% 6.48% 550K
|
Health Technology
|
| O: 0.0%
H: 2.46%
C: 0.49%
day pipeline therapeutics therapy
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.455 -2.88% -2.97% 11K
|
Health Technology
| Email alert
Add to watchlist
pharma key
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVO | $7.47 5.66% 5.35% 34K
|
Manufacturing
|
| O: 1.0%
H: 0.0%
C: 0.0%
year for results
ATEC to Report First Quarter Financial Results on May 7, 2024
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
ATEC | $12.81 2.15% 2.03% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
first report financial results
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
AFMD | $5.0 -2.91% -3.0% 96K
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
allonk first candidate lupus cell trial therapy
InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
SLP | $45.01 -0.33% -0.33% 90K
|
Technology Services
|
| O: 0.86%
H: 0.68%
C: -2.3%
drug solutions for plus
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
PPCB | $0.0011 -41.86% 5.6M
|
Manufacturing
|
| O: 0.0%
H: 14.29%
C: -7.14%
patent cancer biopharma for grant
Pelthos Therapeutics Establishes Board of Directors
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
SVRA | $4.71 -2.08% -2.12% 680K
|
Health Technology
|
| O: -0.79%
H: 6.0%
C: 3.2%
INSM | $24.11 -0.86% -0.87% 3.3M
|
Health Technology
|
| O: 0.19%
H: 0.41%
C: -2.68%
therapeutics
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
announcement conference for financial results
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Published: 2024-04-15 (Crawled : 15:00) - biospace.com/
ZLAB | $14.97 6.4% 6.01% 460K
|
Health Technology
|
| O: -1.33%
H: 2.66%
C: 0.57%
first financial results
$4.9B Vertex-Alpine Deal Highlights Continued 2024 M&A Upswing
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
deal
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: 104.91%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 0.0%
H: 2.97%
C: 2.97%
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: -0.47%
H: 0.48%
C: -0.95%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 8.53%
H: 25.0%
C: 12.86%
MOR | News | $17.97 -0.06% -0.06% 330K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
GLPG | News | $29.09 0.03% -0.14% 80K
|
Health Technology
|
| O: 0.55%
H: 0.29%
C: -1.41%
AMRN | News | $0.8648 0.64% 0.64% 740K
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: -1.92%
GOOGL | News S | $156.3 1.43% 1.41% 26M
|
Technology Services
|
| O: 0.49%
H: 1.77%
C: 1.59%
GOOG | News S | $157.96 1.44% 1.42% 15M
|
Technology Services
|
| O: 0.43%
H: 1.76%
C: 1.55%
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: -1.62%
H: 4.43%
C: 3.67%
biopharma novartis
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
ADCT | $4.69 -0.64% 0.0% 170K
|
Health Technology
|
| O: 0.4%
H: 7.17%
C: 1.39%
merck
Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
ALKS | $24.06 0.88% 0.87% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
lybalvi congress international research schizophrenia study
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
HUGE | News | $0.499 6.19% 5.83% 680K
|
Process Industries
|
| O: -1.51%
H: 5.48%
C: -0.56%
pharma nasdaq
RenovoRx Announces $11.1 Million at Market Private Placement
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
RNXT | $1.23 5.13% 4.88% 4.3K
|
|
| O: -1.71%
H: 34.78%
C: 1.74%
million market
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences - April 8, 2024
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
GRTS | $0.7453 1.18% 1.17% 3.4M
|
Health Technology
|
| O: -1.48%
H: 4.0%
C: 1.0%
Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
fda approval
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.